eMedicine Specialties > Emergency Medicine > Cardiovascular

Pulmonic Valvular Stenosis

Author: David J Wallace, MD, MPH, Critical Care Medicine Fellow, University of Pittsburgh Medical Center
Coauthor(s): Mert Erogul, MD, Assistant Professor of Emergency Medicine, University Hospital of Brooklyn: Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center; Kurt Pflieger, MD, FAAP, Active Staff, Department of Pediatrics, Lake Pointe Medical Center
Contributor Information and Disclosures

Updated: Jul 3, 2008

Introduction

Background

Until the 1950s, isolated pulmonary stenosis was considered to be a rare congenital abnormality.1 A review of the literature in 1949 yielded just 68 cases. However, as physiologic testing has improved, this condition has been more frequently recognized.

Pulmonary valve stenosis (PVS) is described as those lesions that collectively are associated with obstruction to right ventricular outflow. PVS may be valvular, subvalvular, or supravalvular. PVS is the cause of isolated right ventricular outflow obstruction in 80% of cases.2

Pathophysiology

The pulmonic valve develops between the 6th and 9th week of gestation. Normally, the pulmonic valve is formed from 3 swellings of subendocardial tissue called the semilunar valves. These tubercles develop around the orifice of the pulmonary tree. The swellings are normally hollowed out and reshaped to form the 3 thin-walled cusps of the pulmonary valve.

Failure to develop normally can result in the following malformations: fusion of 2 of the cusps, 3 leaflets that are thickened and partially fused at the commissures, or a single cone-shaped valve. In Noonan syndrome, tissue pads within the sinuses interfere with the normal mobility and function of the valve.

The most common pathology is valvular pulmonic stenosis, which accounts for more than 80% of cases of pulmonary stenosis. Most cases are isolated valvular conditions, but they may be associated with a ventricular septal defect or secondarily lead to right ventricular infundibular hypertrophy.3

Isolated infundibular or subvalvular pulmonic stenosis is less common and is usually associated with a ventricular septal defect.

Most cases are congenital and sporadic. PVS is not understood to have significant inheritance, but its concordance among siblings is higher than would be expected. Rarely, pulmonic stenosis is associated with recessively transmitted conditions such as Laurence-Moon-Biedl syndrome. Isolated pulmonic stenosis has been reported in association with trisomy 21, and infundibular stenosis has been associated with trisomy 18, 15, and 13. In patients with Noonan syndrome, pulmonic stenosis, classically with dysplastic valves, can be present. Additionally, in the congenital rubella syndrome, supravalvular pulmonic and pulmonary artery branch stenoses are frequently present.

Acquired valvular disease is rare. The two most common etiologies are carcinoid and rheumatic fever.

Frequency

United States

PVS accounts for 10% of cases of congenital heart disease. Prevalence of pulmonary stenosis is 8-12% of all congenital heart defects. Isolated PVS with intact ventricular septum is the second most common congenital cardiac defect. PVS may occur in as many as 30% of all patients with congenital heart disease when associated with other congenital cardiac lesions.

Mortality/Morbidity

Much of what is known about the morbidity and mortality of PVS comes from the Natural History Study of Congenital Heart Defects and the Second Natural History Study of Congenital Heart Defects. The Natural History Study of Congenital Heart Defects included an initial cardiac catheterization and then follow-up for events over an 8-year period. The Second Natural History Study of Congenital Heart Defects reported on 16-27 years of follow up from the same cohort. The studies demonstrated that adverse outcomes directly relate to the right ventricular systolic pressure gradient.

  • Mild (<50 mm Hg) PVS is well tolerated. Trivial differences were noted in the frequency of electrocardiographic abnormalities, exercise tolerance, echocardiographic findings, and adverse cardiac outcomes for those with pressure gradients less than 50 mm Hg. Of these patients, 94% were asymptomatic, without cyanosis or congestive heart failure.4,5
  • Moderate to severe PVS (>50 mm Hg) can be associated with decreased cardiac output, right ventricular hypertrophy, early congestive heart failure (CHF), and cyanosis.
  • The impact of this valvular lesion on pregnancy and fetal outcomes has not been rigorously studied. A case-control study of 17 patients in 2007 suggested that there is no adverse impact on either the mother or the fetus.6

Sex

The male-to-female ratio is approximately 1:1.

Age

PVS most commonly presents in newborns. It can be asymptomatic for years.

Clinical

History

  • History of a heart murmur since birth
  • Acyanosis
  • Dyspnea
  • Fatigue
  • Dizziness or syncope, occasionally
  • Chest pain

Physical

Physical examination findings correlate with the severity of right ventricular outflow obstruction.

  • The first heart sound is normal and followed by a systolic ejection click. The systolic ejection click is variable with respiration and louder on expiration. It is loudest over the left upper sternal border.
    • Patients with dysplastic valves may not have a systolic ejection click.
    • The second heart sound is split. This is due to delayed closing of the pulmonic valve at the end of systole. The pulmonic component of the second heart sound may be diminished in intensity.
  • Systolic ejection murmur (crescendo-decrescendo), grade 2-5/6, is audible at the left upper sternal border, transmitting into the back and posterior lung fields. The murmur is heard best in the 1st to 3rd intercostal spaces.
  • Severity of valvular disease is related directly to the intensity and duration of the murmur. When severe, murmur extends into diastole (beyond the second heart sound).
  • Hepatosplenomegaly may develop in cases of CHF.
  • Severe PVS is associated with tricuspid insufficiency and may be associated with elevated central venous pressure, hepatosplenomegaly, a pulsatile liver, jugular venous pulsations, and hepatojugular reflux.
  • Murmur of peripheral pulmonary stenosis (commonly encountered in neonates) is a grade 2/6 systolic murmur that radiates into the posterior lung fields.
    • Pathology of peripheral pulmonic stenosis is secondary to the acute angular takeoff of the branch pulmonary arteries from the main pulmonary arteries specific to a neonatal anatomy. This condition and associated murmur usually resolve spontaneously in the first month of life.
  • Myocardial infarction of hypertrophied right ventricle may occur.
  • Prominent A wave of the jugular venous pulse is observed.
  • Tricuspid regurgitation occasionally is present.
  • The murmur usually radiates to the clavicles, the suprasternal area, and left neck. Radiation down the left sternal border is less common.

Causes

  • PVS primarily results from a maldevelopment of the pulmonic valve tissue and the distal portion of the bulbus cordis. One maldevelopment is characterized by fusion of leaflet commissures, resulting in a domed appearance to the valve. Other etiologies result in dysplastic valves, which do not open and close normally.
  • Coexisting cardiac malformations (eg, ventricular septal defect, atrial septal defect, patent ductus arteriosus) may complicate the anatomy, physiology, and clinical picture.
  • Aberrant flow patterns in utero also may be associated, in part, with maldevelopment of the pulmonary valve.
  • Rubella embryopathy may cause PVS.
  • Family history is a mild risk factor.7
  • Cases have been reported in the setting of Mayer-Rokitansky-Kuster-Hauser syndrome.8

More on Pulmonic Valvular Stenosis

Overview: Pulmonic Valvular Stenosis
Differential Diagnoses & Workup: Pulmonic Valvular Stenosis
Treatment & Medication: Pulmonic Valvular Stenosis
Follow-up: Pulmonic Valvular Stenosis
References

References

  1. Blount SG, Komesu S, McCord MC. Asymptomatic isolated valvular pulmonary stenosis; diagnosis by clinical methods. N Engl J Med. Jan 1 1953;248(1):5-11. [Medline].

  2. Fyler DC. Pulmonary stenosis. In: Nadas Pediatric Cardiology. 1992:459-70.

  3. Moore K, Persaud T. The Developing Human. In: Clinically Oriented Embryology. 1998.

  4. Driscoll DJ, Wolfe RR, Gersony WM, et al. Cardiorespiratory responses to exercise of patients with aortic stenosis, pulmonary stenosis, and ventricular septal defect. Circulation. Feb 1993;87(2 Suppl):I102-13. [Medline].

  5. Ardura J, Gonzalez C, Andres J. Does mild pulmonary stenosis progress during childhood? A study of its natural course. Clin Cardiol. Sep 2004;27(9):519-22. [Medline].

  6. Hameed AB, Goodwin TM, Elkayam U. Effect of pulmonary stenosis on pregnancy outcomes--a case-control study. Am Heart J. Nov 2007;154(5):852-4. [Medline].

  7. Driscoll DJ, Michels VV, Gersony WM, et al. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. Feb 1993;87(2 Suppl):I114-20. [Medline].

  8. Kula S, Saygili A, Tunaoglu FS, et al. Mayer-Rokitansky-Küster-Hauser syndrome associated with pulmonary stenosis. Acta Paediatr. Apr 2004;93(4):570-2. [Medline].

  9. Nishimura RA, Pieroni DR, Bierman FZ, et al. Second natural history study of congenital heart defects. Pulmonary stenosis: echocardiography. Circulation. Feb 1993;87(2 Suppl):I73-9. [Medline].

  10. Silverman NH. Right heart obstructive lesions. In: Pediatric Echocardiography. 1993;327.

  11. Snider AR, Serwer GA. Abnormalities to right ventricular outflow. In: Echocardiography in Pediatric Heart Disease. 1990:231-41.

  12. Sato Y, Komatsu S, Matsuo S, et al. Isolated subvalvular pulmonary stenosis: depiction at whole heart magnetic resonance imaging. Int J Cardiovasc Imaging. Feb 2007;23(1):49-52. [Medline].

  13. Seibt C, Flender B, Gutberlet M. Comprehensive non-invasive pre-surgical magnetic resonance imaging in a patient with LEOPARD's syndrome cardiomyopathy. Eur Heart J. Jun 2006;27(12):1407. [Medline].

  14. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation. Feb 1993;87(2 Suppl):I89-101. [Medline].

  15. Kan JS, White RI Jr, Mitchell SE, et al. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. Aug 26 1982;307(9):540-2. [Medline].

  16. Bonhoeffer P, Boudjemline Y, Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. May 15 2002;39(10):1664-9. [Medline].

  17. Block PC, Bonhoeffer P. Percutaneous approaches to valvular heart disease. Curr Cardiol Rep. Mar 2005;7(2):108-13. [Medline].

  18. Castenada AR, Jonas RA, Meyer JE. Surgery for infants with congenital heart defects. In: Cardiac Surgery. 1993:1013-35.

  19. Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. Feb 1993;87(2 Suppl):I121-6. [Medline].

  20. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. Oct 9 2007;116(15):1736-54. [Medline].

  21. Fawzy ME, Hassan W, Fadel BM, et al. Long-term results (up to 17 years) of pulmonary balloon valvuloplasty in adults and its effects on concomitant severe infundibular stenosis and tricuspid regurgitation. Am Heart J. Mar 2007;153(3):433-8. [Medline].

  22. Almeda FQ, Kavinsky CJ, Pophal SG, et al. Pulmonic valvular stenosis in adults: diagnosis and treatment. Catheter Cardiovasc Interv. Dec 2003;60(4):546-57. [Medline].

  23. Park MK. Pulmonary stenosis. In: Pediatric Cardiology for Practitioners. 145-7.

  24. Rocchini AP, Emmanouilides GC. Pulmonary stenosis. In: Heart Disease in Infants, Children and Adolescent: Including the Fetus and Young Adult. 930-62.

Further Reading

Keywords

pulmonary valvular stenosis, pulmonary valve stenosis, PVS, pulmonary stenosis, valvular, subvalvular, supravalvular, lesions, right ventricular outflow obstruction, Laurence-Moon-Biedl syndrome, Noonan syndrome, trisomy 21, cardiac malformations

Contributor Information and Disclosures

Author

David J Wallace, MD, MPH, Critical Care Medicine Fellow, University of Pittsburgh Medical Center
David J Wallace, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents Association, Society for Academic Emergency Medicine, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Mert Erogul, MD, Assistant Professor of Emergency Medicine, University Hospital of Brooklyn: Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Mert Erogul, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Kurt Pflieger, MD, FAAP, Active Staff, Department of Pediatrics, Lake Pointe Medical Center
Kurt Pflieger, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Peter MC DeBlieux, MD, Professor of Clinical Medicine and Pediatrics, Section of Pulmonary and Critical Care Medicine, Program Director, Department of Emergency Medicine, Louisiana State University Health Sciences Center
Peter MC DeBlieux, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Radiological Society of North America, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

David Eitel, MD, MBA, Associate Professor, Department of Emergency Medicine, York Hospital
David Eitel, MD, MBA is a member of the following medical societies: American College of Emergency Physicians, Society for Academic Emergency Medicine, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.